We are seeing flu case numbers spike upward through the U.S., including here in Massachusetts. The flu season is definitely upon us and unfortunately it is not showing signs of slowing down. According to CDC,
The map of flu activity across the United States continues to darken, both figuratively and literally, as case numbers spike upward in most states, according to the Centers for Disease Control and Prevention (CDC).
A man died Monday in Louisiana after contracting the bird flu virus after being exposed to birds. By December the CDC had identified at least 65 human infections of avian flu in the United States, more than half (36) in the state of California,
Massachusetts officials suspect more than 60 birds found dead in Plymouth died from bird flu, though official results may not come for days.
D.W. Field Park, a large park in Brockton and Avon, Massachusetts, was closed on Friday, with officials warning of a potential bird flu outbreak and warning the public not to touch any birds that are dead or hurt.
State officials issued guidelines for potential bird flu cases Wednesday morning. State officials held a news conference Wednesday morning with an update on bird flu in Massachusetts. Two geese at UMass tested positive for the disease last week,
The progression of the species-jumping disease has been unprecedented, including the first-ever U.S. cases of infections in dairy cattle and heightened pandemic risks.
The killings of a Border Patrol agent in Vermont last week, a state’s witness in California, and a pair of senior citizens in Pennsylvania all appear to be linked to a fringe group of West Coast vegan activists and artificial intelligence theorists.
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.
The man who hopes to be President Donald Trump’s health secretary repeatedly asked to see “data” or “science” showing vaccines are safe – but when an influential Republican
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval